These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24866785)

  • 1. Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action.
    Gubellini P; Melon C; Dale E; Doller D; Kerkerian-Le Goff L
    Neuropharmacology; 2014 Oct; 85():166-77. PubMed ID: 24866785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergy between L-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: implications for Parkinson's disease treatment and dyskinesia.
    Bennouar KE; Uberti MA; Melon C; Bacolod MD; Jimenez HN; Cajina M; Kerkerian-Le Goff L; Doller D; Gubellini P
    Neuropharmacology; 2013 Mar; 66():158-69. PubMed ID: 22491024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex.
    Bogenpohl J; Galvan A; Hu X; Wichmann T; Smith Y
    Neuropharmacology; 2013 Mar; 66():242-52. PubMed ID: 22634360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabotropic Glutamate Receptor 4 (mGlu4) Positive Allosteric Modulators Lack Efficacy in Rat and Marmoset Models of L-DOPA-Induced Dyskinesia.
    Finlay CJ; Jackson MJ; Fisher R; Bundgaard C; Rose S; Duty S
    J Parkinsons Dis; 2024; 14(2):245-259. PubMed ID: 38427500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.
    Niswender CM; Jones CK; Lin X; Bubser M; Thompson Gray A; Blobaum AL; Engers DW; Rodriguez AL; Loch MT; Daniels JS; Lindsley CW; Hopkins CR; Javitch JA; Conn PJ
    ACS Chem Neurosci; 2016 Sep; 7(9):1201-11. PubMed ID: 27441572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents.
    Sławińska A; Wierońska JM; Stachowicz K; Marciniak M; Lasoń-Tyburkiewicz M; Gruca P; Papp M; Kusek M; Tokarski K; Doller D; Pilc A
    Br J Pharmacol; 2013 Aug; 169(8):1824-39. PubMed ID: 23714045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist.
    Iderberg H; Maslava N; Thompson AD; Bubser M; Niswender CM; Hopkins CR; Lindsley CW; Conn PJ; Jones CK; Cenci MA
    Neuropharmacology; 2015 Aug; 95():121-9. PubMed ID: 25749357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism.
    Beurrier C; Lopez S; Révy D; Selvam C; Goudet C; Lhérondel M; Gubellini P; Kerkerian-LeGoff L; Acher F; Pin JP; Amalric M
    FASEB J; 2009 Oct; 23(10):3619-28. PubMed ID: 19525404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies.
    Wierońska JM; Sławińska A; Łasoń-Tyburkiewicz M; Gruca P; Papp M; Zorn SH; Doller D; Kłeczek N; Noworyta-Sokołowska K; Gołembiowska K; Pilc A
    Psychopharmacology (Berl); 2015 Jan; 232(1):259-73. PubMed ID: 25012236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of GABAergic transmission in the striatopallidal system by adenosine A2A receptors: a potential mechanism for the antiparkinsonian effects of A2A antagonists.
    Mori A; Shindou T
    Neurology; 2003 Dec; 61(11 Suppl 6):S44-8. PubMed ID: 14663009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse.
    Valenti O; Marino MJ; Wittmann M; Lis E; DiLella AG; Kinney GG; Conn PJ
    J Neurosci; 2003 Aug; 23(18):7218-26. PubMed ID: 12904482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson's disease.
    Jones CK; Bubser M; Thompson AD; Dickerson JW; Turle-Lorenzo N; Amalric M; Blobaum AL; Bridges TM; Morrison RD; Jadhav S; Engers DW; Italiano K; Bode J; Daniels JS; Lindsley CW; Hopkins CR; Conn PJ; Niswender CM
    J Pharmacol Exp Ther; 2012 Feb; 340(2):404-21. PubMed ID: 22088953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats.
    Ossowska K; Wardas J; Berghauzen-Maciejewska K; Głowacka U; Kuter K; Pilc A; Zorn SH; Doller D
    Neuropharmacology; 2014 Aug; 83():28-35. PubMed ID: 24726309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal NTS1 , dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release--a dual-probe microdialysis study in the intranigral 6-hydroxydopamine unilaterally lesioned rat.
    Ferraro L; O'Connor WT; Beggiato S; Tomasini MC; Fuxe K; Tanganelli S; Antonelli T
    Eur J Neurosci; 2012 Jan; 35(2):207-20. PubMed ID: 22211865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine-dependent corticostriatal synaptic filtering regulates sensorimotor behavior.
    Wong MY; Borgkvist A; Choi SJ; Mosharov EV; Bamford NS; Sulzer D
    Neuroscience; 2015 Apr; 290():594-607. PubMed ID: 25637802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted mGluR Activation Disinhibits Striatopallidal Transmission in Parkinsonian Mice.
    Cui Q; Pitt JE; Pamukcu A; Poulin JF; Mabrouk OS; Fiske MP; Fan IB; Augustine EC; Young KA; Kennedy RT; Awatramani R; Chan CS
    Cell Rep; 2016 Nov; 17(9):2431-2444. PubMed ID: 27880915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor.
    Sławińska A; Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Uberti MA; Bacolod MA; Doller D; Pilc A
    Neuropharmacology; 2013 Mar; 66():225-35. PubMed ID: 22634361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabotropic glutamate receptor subtype 4 selectively modulates both glutamate and GABA transmission in the striatum: implications for Parkinson's disease treatment.
    Cuomo D; Martella G; Barabino E; Platania P; Vita D; Madeo G; Selvam C; Goudet C; Oueslati N; Pin JP; Acher F; Pisani A; Beurrier C; Melon C; Kerkerian-Le Goff L; Gubellini P
    J Neurochem; 2009 May; 109(4):1096-105. PubMed ID: 19519781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.
    Nouhi M; Zhang X; Yao N; Chergui K
    CNS Neurosci Ther; 2018 Feb; 24(2):144-153. PubMed ID: 29230960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.